Optimising malignant melanoma management in Europe
EUMelaReg collects health information to improve care and treatment for patients with skin cancer
Sustaining and fostering collaboration between academia and industry
for the collection of baseline, treatment and outcome data of representative samples of malignant melanoma patients of major European countries.
Building the largest and quickest melanoma registry in the world
EUMelaReg collects real-world data on melanoma patients throughout Europe and integrates them in a data warehouse.

EUMelaReg Steering Committee Member John Haanen receives prestigious ESMO Lifetime Achievement Award

We are proud to announce that our EUMelaReg board member John Haanen received the prestigious ESMO Lifetime Achievement Award at ESMO 2024, which honors outstanding lifetime achievements in oncology. This award celebrates John Haanen's outstanding commitment to clinical cancer research at an international level. John is recognized for his excellent research into the development of novel immunotherapies, particularly tumor-infiltrating lymphocyte (TIL) therapies for advanced melanoma. Thank you, John, for all your effort and engagement. We are proud that you are part of EUMelaReg.